Tower Research Capital LLC (TRC) - KINIKSA PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$22,303
-28.1%
1,284
-41.7%
0.00%0.0%
Q2 2023$31,004
+58398.1%
2,202
-55.2%
0.00%
-50.0%
Q1 2023$53
+307.7%
4,915
+437.7%
0.00%
+100.0%
Q4 2022$13
-100.0%
914
-70.3%
0.00%0.0%
Q3 2022$39,000
-7.1%
3,077
-28.1%
0.00%0.0%
Q2 2022$42,000
+68.0%
4,280
+69.5%
0.00%
Q1 2022$25,000
-73.4%
2,525
-68.4%
0.00%
-100.0%
Q4 2021$94,000
+88.0%
7,984
+78.5%
0.00%
+100.0%
Q3 2021$50,000
-35.1%
4,474
-18.7%
0.00%
-50.0%
Q2 2021$77,000
+208.0%
5,501
+312.4%
0.00%
Q1 2021$25,000
-49.0%
1,334
-51.5%
0.00%
-100.0%
Q4 2020$49,000
-83.6%
2,750
-85.8%
0.00%
-66.7%
Q3 2020$298,000
+338.2%
19,421
+622.5%
0.00%0.0%
Q2 2020$68,000
+209.1%
2,688
+87.4%
0.00%
+200.0%
Q1 2020$22,000
-71.1%
1,434
-79.0%
0.00%
-83.3%
Q4 2019$76,0006,814
+22613.3%
0.01%
Q3 2019$0
-100.0%
30
-94.0%
0.00%
-100.0%
Q1 2019$9,000
-71.0%
498
-58.5%
0.00%
-50.0%
Q3 2018$31,000
+675.0%
1,199
+421.3%
0.00%
Q2 2018$4,0002300.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders